The initial Phase 2a data build on results presented at the 2025 San Antonio Breast Cancer Symposium, demonstrating encouraging clinical activity ...
News
- Marengo Reports Late-Breaking Initial Phase 2 Clinical Results from Invikafusp Alfa Plus ...
- Ben Adams Jewelers Announces Going Out of Business Sale After 56
SAN ANTONIO, TX, UNITED STATES, April 17, 2026 /EINPresswire.com ... Biotech, Food, & Drug · Business of Law · Construction & Real Estate ...
- Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors - BioSpace
... Bioscience, Inc., and as chief scientific officer at Zimmer, Inc. ... San Antonio, Texas. She currently serves on the board of directors of ...
- Popular Bay Area Barnes & Noble offers steep discounts as it prepares to close - MSN
... biotech and life science campus. ... Book with Early 2026 Deals and stay until April. Sponsored. Popular San Antonio boutique's shutdown stuns vendors ...
- Logjam of U.S. immigration applications puts millions at greater risk of deportation | TPR
Cytotoxic T cells (blue with pink) drive · Bioscience ... A therapy that could revolutionize cancer treatment is getting a clinical trial in San Antonio.